Otsuka Holdings Co., Ltd. (OTSKF)
USD 57.15
(0.0%)
USD 57.15
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3361.24 Billion JPY | 8.33% |
| 2022 | 3102.71 Billion JPY | 9.99% |
| 2021 | 2820.91 Billion JPY | 7.35% |
| 2020 | 2627.8 Billion JPY | 1.8% |
| 2019 | 2581.3 Billion JPY | 4.23% |
| 2018 | 2476.63 Billion JPY | -0.15% |
| 2017 | 2480.25 Billion JPY | 0.08% |
| 2016 | 2478.29 Billion JPY | -1.99% |
| 2015 | 2528.5 Billion JPY | 12.95% |
| 2014 | 2238.66 Billion JPY | 25.82% |
| 2013 | 1779.2 Billion JPY | 6.75% |
| 2012 | 1666.76 Billion JPY | 4.85% |
| 2011 | 1589.63 Billion JPY | 9.0% |
| 2010 | 1458.37 Billion JPY | 12.29% |
| 2009 | 1298.78 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3449.78 Billion JPY | 2.63% |
| 2024 Q2 | 3660.63 Billion JPY | 6.11% |
| 2023 FY | 3361.24 Billion JPY | 8.33% |
| 2023 Q2 | 3308.77 Billion JPY | 5.64% |
| 2023 Q3 | 3417.97 Billion JPY | 3.3% |
| 2023 Q4 | 3361.24 Billion JPY | -1.66% |
| 2023 Q1 | 3132.04 Billion JPY | 0.95% |
| 2022 Q2 | 3101.28 Billion JPY | 7.46% |
| 2022 Q1 | 2886.02 Billion JPY | 2.31% |
| 2022 Q3 | 3187.73 Billion JPY | 2.79% |
| 2022 FY | 3102.71 Billion JPY | 9.99% |
| 2022 Q4 | 3102.71 Billion JPY | -2.67% |
| 2021 FY | 2820.91 Billion JPY | 7.35% |
| 2021 Q3 | 2815.76 Billion JPY | 3.06% |
| 2021 Q4 | 2820.91 Billion JPY | 0.18% |
| 2021 Q1 | 2699.82 Billion JPY | 2.74% |
| 2021 Q2 | 2732.17 Billion JPY | 1.2% |
| 2020 Q1 | 2532.16 Billion JPY | -1.9% |
| 2020 Q2 | 2581.21 Billion JPY | 1.94% |
| 2020 Q3 | 2582.92 Billion JPY | 0.07% |
| 2020 Q4 | 2627.8 Billion JPY | 1.74% |
| 2020 FY | 2627.8 Billion JPY | 1.8% |
| 2019 Q2 | 2610.65 Billion JPY | -0.22% |
| 2019 Q4 | 2581.3 Billion JPY | -1.19% |
| 2019 Q1 | 2616.43 Billion JPY | 5.64% |
| 2019 Q3 | 2612.29 Billion JPY | 0.06% |
| 2019 FY | 2581.3 Billion JPY | 4.23% |
| 2018 Q2 | 2507.91 Billion JPY | 3.49% |
| 2018 Q4 | 2476.63 Billion JPY | -3.95% |
| 2018 Q3 | 2578.46 Billion JPY | 2.81% |
| 2018 Q1 | 2423.26 Billion JPY | -2.3% |
| 2018 FY | 2476.63 Billion JPY | -0.15% |
| 2017 Q2 | 2430.81 Billion JPY | 0.28% |
| 2017 FY | 2480.25 Billion JPY | 0.08% |
| 2017 Q3 | 2467.73 Billion JPY | 1.52% |
| 2017 Q4 | 2480.25 Billion JPY | 0.51% |
| 2017 Q1 | 2424.05 Billion JPY | -2.19% |
| 2016 Q1 | 2415.91 Billion JPY | -4.45% |
| 2016 FY | 2478.29 Billion JPY | -1.99% |
| 2016 Q3 | 2302.2 Billion JPY | -0.71% |
| 2016 Q4 | 2478.29 Billion JPY | 7.65% |
| 2016 Q2 | 2318.6 Billion JPY | -4.03% |
| 2015 Q3 | 2550.35 Billion JPY | 2.28% |
| 2015 FY | 2528.5 Billion JPY | 12.95% |
| 2015 Q4 | 2528.5 Billion JPY | -0.86% |
| 2015 Q2 | 2493.39 Billion JPY | 4.23% |
| 2015 Q1 | 2392.23 Billion JPY | 0.0% |
| 2014 Q2 | 1996.25 Billion JPY | -1.58% |
| 2014 FY | 2238.66 Billion JPY | 25.82% |
| 2014 Q3 | 2094.22 Billion JPY | 4.91% |
| 2014 Q1 | 2028.39 Billion JPY | 7.66% |
| 2013 Q2 | 1805.83 Billion JPY | 1.5% |
| 2013 FY | 1779.2 Billion JPY | 6.75% |
| 2013 Q4 | 1884.09 Billion JPY | 1.05% |
| 2013 Q3 | 1864.46 Billion JPY | 3.25% |
| 2013 Q1 | 1779.2 Billion JPY | 7.79% |
| 2012 Q4 | 1650.56 Billion JPY | -2.31% |
| 2012 Q2 | 1682.08 Billion JPY | 0.92% |
| 2012 FY | 1666.76 Billion JPY | 4.85% |
| 2012 Q1 | 1666.76 Billion JPY | 0.38% |
| 2012 Q3 | 1689.57 Billion JPY | 0.44% |
| 2011 FY | 1589.63 Billion JPY | 9.0% |
| 2011 Q1 | 1589.63 Billion JPY | 1.3% |
| 2011 Q2 | 1647.69 Billion JPY | 3.65% |
| 2011 Q3 | 1675.54 Billion JPY | 1.69% |
| 2011 Q4 | 1660.41 Billion JPY | -0.9% |
| 2010 Q1 | 1458.37 Billion JPY | 1.79% |
| 2010 Q4 | 1569.19 Billion JPY | 9.03% |
| 2010 Q3 | 1439.21 Billion JPY | 0.1% |
| 2010 Q2 | 1437.71 Billion JPY | -1.42% |
| 2010 FY | 1458.37 Billion JPY | 12.29% |
| 2009 Q4 | 1432.79 Billion JPY | -0.07% |
| 2009 Q3 | 1433.74 Billion JPY | 2.91% |
| 2009 FY | 1298.78 Billion JPY | 0.0% |
| 2009 Q2 | 1393.23 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AstraZeneca PLC | 100.97 Billion USD | -3228.748% |
| Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | -3432.24% |
| CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -51421.104% |
| Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -6500333.202% |
| Novartis AG | 99.94 Billion USD | -3263.094% |
| PT Kalbe Farma Tbk. | 1.75 Billion USD | -191016.385% |